2-208121822-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_006891.4(CRYGD):​c.376G>A​(p.Val126Met) variant causes a missense change. The variant allele was found at a frequency of 0.00243 in 1,614,118 control chromosomes in the GnomAD database, including 9 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0021 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0025 ( 9 hom. )

Consequence

CRYGD
NM_006891.4 missense

Scores

6
10
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 4.02

Publications

10 publications found
Variant links:
Genes affected
CRYGD (HGNC:2411): (crystallin gamma D) Crystallins are separated into two classes: taxon-specific, or enzyme, and ubiquitous. The latter class constitutes the major proteins of vertebrate eye lens and maintains the transparency and refractive index of the lens. Since lens central fiber cells lose their nuclei during development, these crystallins are made and then retained throughout life, making them extremely stable proteins. Mammalian lens crystallins are divided into alpha, beta, and gamma families; beta and gamma crystallins are also considered as a superfamily. Alpha and beta families are further divided into acidic and basic groups. Seven protein regions exist in crystallins: four homologous motifs, a connecting peptide, and N- and C-terminal extensions. Gamma-crystallins are a homogeneous group of highly symmetrical, monomeric proteins typically lacking connecting peptides and terminal extensions. They are differentially regulated after early development. Four gamma-crystallin genes (gamma-A through gamma-D) and three pseudogenes (gamma-E, gamma-F, gamma-G) are tandemly organized in a genomic segment as a gene cluster. Whether due to aging or mutations in specific genes, gamma-crystallins have been involved in cataract formation. [provided by RefSeq, Jul 2008]
CRYGD Gene-Disease associations (from GenCC):
  • cataract 4 multiple types
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
  • cataract - microcornea syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • cerulean cataract
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • coralliform cataract
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • early-onset lamellar cataract
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • early-onset nuclear cataract
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • pulverulent cataract
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.01816386).
BP6
Variant 2-208121822-C-T is Benign according to our data. Variant chr2-208121822-C-T is described in ClinVar as [Benign]. Clinvar id is 333869.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00211 (321/152228) while in subpopulation NFE AF = 0.00396 (269/68004). AF 95% confidence interval is 0.00357. There are 0 homozygotes in GnomAd4. There are 143 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 321 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CRYGDNM_006891.4 linkc.376G>A p.Val126Met missense_variant Exon 3 of 3 ENST00000264376.5 NP_008822.2 P07320A0A140CTX7
LOC100507443NR_038437.1 linkn.97+2597C>T intron_variant Intron 1 of 2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CRYGDENST00000264376.5 linkc.376G>A p.Val126Met missense_variant Exon 3 of 3 1 NM_006891.4 ENSP00000264376.4 P07320

Frequencies

GnomAD3 genomes
AF:
0.00211
AC:
321
AN:
152110
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000314
Gnomad AMI
AF:
0.00658
Gnomad AMR
AF:
0.000720
Gnomad ASJ
AF:
0.00144
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00142
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00396
Gnomad OTH
AF:
0.000956
GnomAD2 exomes
AF:
0.00190
AC:
479
AN:
251480
AF XY:
0.00187
show subpopulations
Gnomad AFR exome
AF:
0.000185
Gnomad AMR exome
AF:
0.000549
Gnomad ASJ exome
AF:
0.00109
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.00129
Gnomad NFE exome
AF:
0.00359
Gnomad OTH exome
AF:
0.00130
GnomAD4 exome
AF:
0.00247
AC:
3609
AN:
1461890
Hom.:
9
Cov.:
70
AF XY:
0.00246
AC XY:
1788
AN XY:
727246
show subpopulations
African (AFR)
AF:
0.000299
AC:
10
AN:
33480
American (AMR)
AF:
0.000537
AC:
24
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00145
AC:
38
AN:
26136
East Asian (EAS)
AF:
0.0000756
AC:
3
AN:
39700
South Asian (SAS)
AF:
0.0000116
AC:
1
AN:
86258
European-Finnish (FIN)
AF:
0.00178
AC:
95
AN:
53416
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
0.00301
AC:
3349
AN:
1112012
Other (OTH)
AF:
0.00147
AC:
89
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.471
Heterozygous variant carriers
0
235
469
704
938
1173
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
100
200
300
400
500
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00211
AC:
321
AN:
152228
Hom.:
0
Cov.:
32
AF XY:
0.00192
AC XY:
143
AN XY:
74422
show subpopulations
African (AFR)
AF:
0.000313
AC:
13
AN:
41548
American (AMR)
AF:
0.000720
AC:
11
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.00144
AC:
5
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5188
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4816
European-Finnish (FIN)
AF:
0.00142
AC:
15
AN:
10592
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00396
AC:
269
AN:
68004
Other (OTH)
AF:
0.000946
AC:
2
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.491
Heterozygous variant carriers
0
15
30
44
59
74
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00317
Hom.:
4
Bravo
AF:
0.00168
TwinsUK
AF:
0.00243
AC:
9
ALSPAC
AF:
0.00234
AC:
9
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.00314
AC:
27
ExAC
AF:
0.00208
AC:
253
Asia WGS
AF:
0.000577
AC:
2
AN:
3478
EpiCase
AF:
0.00284
EpiControl
AF:
0.00231

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jul 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

CRYGD: BS1, BS2 -

Cataract 4 multiple types Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

CRYGD-related disorder Benign:1
Sep 13, 2019
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Aculeiform cataract Benign:1
Jan 28, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.66
BayesDel_addAF
Uncertain
0.10
D
BayesDel_noAF
Pathogenic
0.37
CADD
Uncertain
23
DANN
Uncertain
1.0
DEOGEN2
Pathogenic
0.87
D
Eigen
Uncertain
0.65
Eigen_PC
Uncertain
0.47
FATHMM_MKL
Uncertain
0.87
D
M_CAP
Uncertain
0.12
D
MetaRNN
Benign
0.018
T
MetaSVM
Uncertain
0.77
D
MutationAssessor
Pathogenic
4.3
H
PhyloP100
4.0
PrimateAI
Uncertain
0.52
T
PROVEAN
Uncertain
-2.7
D
REVEL
Pathogenic
0.83
Sift
Pathogenic
0.0
D
Sift4G
Uncertain
0.029
D
Polyphen
1.0
D
Vest4
0.26
MVP
0.90
MPC
0.84
ClinPred
0.14
T
GERP RS
3.4
Varity_R
0.80
gMVP
0.40
Mutation Taster
=81/19
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs150318966; hg19: chr2-208986546; API